Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00756730 · ClinicalTrials.gov registry record · Phase 4
Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r
A Phase 4 study, sponsored by Community Research Initiative of New England.
- Completed
- Registry status
- Phase 4
- Development phase
- 49
- Enrollment target
NCT00756730: Completed Phase 4 study, sponsored by Community Research Initiative of New England.
NCT00756730 is a Phase 4 study that has completed, run by Community Research Initiative of New England. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00756730, a Phase 4 study, has completed, sponsored by Community Research Initiative of New England.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 49 participants
- Enrollment target
Study Summary
For participants with HIV taking either lopinavir or fosamprenavir who have elevated triglycerides, this trial will study the change in triglycerides after switching protease inhibitors.
Interventions
- DRUG ATV/r
- DRUG DRV/r
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00756730
The ClinicalTrials.gov registry entry for NCT00756730 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Community Research Initiative of New England, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ATV/r is the first listed.
NCT00756730 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00756730 about?
NCT00756730 is a clinical study titled "Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r". For participants with HIV taking either lopinavir or fosamprenavir who have elevated triglycerides, this trial will study the change in triglycerides after switching protease inhibitors.
What is the current status of trial NCT00756730?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 49 participants. The study started on 2008-09. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00756730?
The interventions under investigation include: ATV/r (DRUG), DRV/r (DRUG).
Who is sponsoring clinical trial NCT00756730?
This trial is sponsored by Community Research Initiative of New England, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.